Article Information
History
- August 2, 2020.
Article Versions
- Version 1 (July 31, 2020 - 23:48).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Thomas Theo Brehm, MD1,2,#,
- Dorothee Schwinge, PhD1,#,
- Sibylle Lampalzer, MD1,
- Veronika Schlicker, BA1,2,
- Julia Küchen1,
- Michelle Thompson1,
- Felix Ullrich1,
- Samuel Huber, MD1,
- Stefan Schmiedel, MD1,2,
- Marylyn M Addo, MD1,2,
- Marc Lütgehetmann, MD2,3,
- Johannes K Knobloch, MD2,3,
- Julian Schulze zur Wiesch, MD1,2,# and
- Ansgar W Lohse, MD1,2,#
- 1I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20249 Hamburg, Germany
- 2German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems
- 3Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20249 Hamburg, Germany
- *Corresponding author; email: a.lohse{at}uke.de
↵# contributed equally
Posted August 02, 2020.
High effectiveness of multimodal infection control interventions in preventing SARS-CoV-2 infections in healthcare professionals: a prospective longitudinal seroconversion study
